Company Registration No. 08323223 (England and Wales)
HALLS PHARMACY ( NORTH EAST ) LIMITED
Unaudited accounts
for the year ended 31 March 2025
HALLS PHARMACY ( NORTH EAST ) LIMITED
Unaudited accounts
Contents
HALLS PHARMACY ( NORTH EAST ) LIMITED
Company Information
for the year ended 31 March 2025
Directors
Ayaz Akram
Abdur Razzak
Company Number
08323223 (England and Wales)
Registered Office
6 KENSINGTON AVENUE
GOSFORTH
NEWCASTLE UPON TYNE
NE3 2HP
Accountants
Caldwell House Consulting
44 Caldwell Road
Birmingham
West Midlands
B9 5TQ
HALLS PHARMACY ( NORTH EAST ) LIMITED
Statement of financial position
as at 31 March 2025
Intangible assets
646,681
337,048
Tangible assets
259,955
260,279
Investments
1,149,092
1,149,092
Cash at bank and in hand
10,313
66,473
Creditors: amounts falling due within one year
(199,952)
(112,758)
Net current assets
7,348
254,362
Total assets less current liabilities
2,063,076
2,000,781
Creditors: amounts falling due after more than one year
(1,724,857)
(1,658,884)
Provisions for liabilities
Net assets
337,057
340,907
Called up share capital
200
200
Profit and loss account
336,857
340,707
Shareholders' funds
337,057
340,907
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 December 2025 and were signed on its behalf by
Ayaz Akram
Director
Company Registration No. 08323223
HALLS PHARMACY ( NORTH EAST ) LIMITED
Notes to the Accounts
for the year ended 31 March 2025
HALLS PHARMACY ( NORTH EAST ) LIMITED is a private company, limited by shares, registered in England and Wales, registration number 08323223. The registered office is 6 KENSINGTON AVENUE, GOSFORTH, NEWCASTLE UPON TYNE, NE3 2HP.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover comprises the invoiced value of goods and pharmacy services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
18% reducing balance basis
Fixtures & fittings
18% reducing balance basis
Intangible fixed assets (including purchased goodwill) is amortised at rates calculated to write off the assets on a straight basis over their estimated useful economic lives. Impairment of intangible fixed assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
4
Intangible fixed assets
Goodwill
At 31 March 2025
1,098,998
Charge for the year
40,367
HALLS PHARMACY ( NORTH EAST ) LIMITED
Notes to the Accounts
for the year ended 31 March 2025
5
Tangible fixed assets
Land & buildings
Plant & machinery
Fixtures & fittings
Total
Cost or valuation
At cost
At cost
At cost
At 1 April 2024
246,072
13,028
75,831
334,931
At 31 March 2025
246,072
13,028
78,099
337,199
At 1 April 2024
-
7,708
66,944
74,652
Charge for the year
-
958
1,634
2,592
At 31 March 2025
-
8,666
68,578
77,244
At 31 March 2025
246,072
4,362
9,521
259,955
At 31 March 2024
246,072
5,320
8,887
260,279
6
Investments
Subsidiary undertakings
Valuation at 1 April 2024
1,149,092
Valuation at 31 March 2025
1,149,092
Amounts falling due within one year
Trade debtors
19,150
10,106
Other debtors
100,000
226,165
8
Creditors: amounts falling due within one year
2025
2024
Trade creditors
190,839
100,231
Taxes and social security
7,871
11,285
Loans from directors
1,242
1,242
9
Creditors: amounts falling due after more than one year
2025
2024
Bank loans
1,302,896
1,376,438
Amounts owed to group undertakings and other participating interests
297,396
262,446
Other creditors
80,000
20,000
Loans from directors
44,565
-
HALLS PHARMACY ( NORTH EAST ) LIMITED
Notes to the Accounts
for the year ended 31 March 2025
10
Deferred taxation
2025
2024
Accelerated capital allowances
1,162
990
Provision at start of year
990
1,208
Charged/(credited) to the profit and loss account
172
(218)
Provision at end of year
1,162
990
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
100 Ordinary shares - Class B of £1 each
100
100
12
Average number of employees
During the year the average number of employees was 12 (2024: 12).